The increase in price target by Morgan Stanley suggests a positive outlook on CME Group's stock, potentially leading to a short-term increase in its stock price. The Equal-Weight rating indicates that the stock is expected to perform in line with the market or sector, but the raised target price signals confidence in some level of outperformance.